Literatur
- 1
American Thoracic Society/European Respiratory Society .
Pretreatment evaluation of non-small-cell lung cancer.
Am J Respir Crit Care Med.
1997;
156
320-332
- 2
Gould M K, Lillington G A.
Strategy and cost in investigating solitary pulmonary nodules.
Thorax.
1998;
53 (Suppl 2)
S32-S37
- 3
Hoffmann H, Dienemann H.
Der pulmonale Rundherd. Prinzipien der Diagnostik.
Dt Ärztebl.
2000;
97
A-1065-1071
- 4
Coleman R E.
PET in lung cancer.
J Nucl Med.
1999;
40
814-820
- 5 Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch C M. Metaanalyse zum Stellenwert
der Positronen-Emissions-Tomographie mit F-18-Fluorodesoxyglukose (FDG-PET) bei Lungentumoren.
Diskussionsbasis der deutschen Konsensus-Konferenz Onko PET 2000. Pneumologie, zur
Veröffentlichung eingereicht 2001
- 6
Gould M K, Maclean C C, Kuschner W G, Rydzak C E, Owens D K.
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass
lesions.
JAMA.
2001;
285
914-924
- 7
Dwamena B A, Sonnad S S, Angobaldo J O, Wahl R L.
Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - meta-analytic
comparison of PET and CT.
Radiology.
1999;
213
530-536
- 8
Gupta N C, Graeber G M, Bishop H A.
Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation
of small (< 1 cm), intermediate (1 to 3 cm) and large (> 3 cm) lymph node lesions.
Chest.
2000;
117
773-778
- 9
Farrell M A, McAdams H P, Herndorn J E, Patz E F.
Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.
Radiology.
2000;
215
886-890
- 10
Kalff V, Hicks R J, MacManus M P. et al .
Clinical impact of 18F Fluorodeoxyglucose positron emisssion tomography in patients with non-small cell
lung cancer: A prospective study.
J Clin Oncol.
2001;
19
111-118
- 11
Tucker R, Coel M, Ko J, Morris P, Druger G, McGuigan P.
Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on patient management:
First year's experience in a clinical center.
J Clin Oncol.
2001;
19
2504-2508
- 12
Gambhir S S, Shepherd J E, Shah B D. et al .
Analytical decision model for the cost-effective management of solitary pulmonary
nodules.
J Clin Oncol.
1998;
16
2113-2125
- 13
Dietlein M, Weber K, Gandjour A. et al .
Cost-effectiveness of FDG-PET for the management of potentially operable non-small
cell lung cancer: priority for a PET-based strategy after nodal-negative CT results.
Eur J Nucl Med.
2000;
27
1598-1609
- 14
Kosuda S, Ichihara K, Watanabe M. et al .
Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D[18]fluorodeoxyglucose
positron emission tomography in patients with pulmonary nodules (non-small cell lung
carcinoma) in Japan.
Chest.
2000;
117
346-353
- 15
Dietlein M, Weber K, Gandjour A. et al .
Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a
decision analysis based on cost reimbursement in Germany.
Eur J Nucl Med.
2000;
27
1441-1456
Prof. Dr. med. D. Ukena
Medizinische Universitätsklinik
Innere Medizin V
66421 Homburg
Email: E-mail: pnduke@med-rz.uni-sb.de
